MIT E25-119/121 and Zoom (See below for full information)
Investigating The Fidelity Of Classic Cardiovascular Metrics In The Context Of A Failing And Mechanically Supported Heart
The advent of mechanical circulatory support devices (MCS) has ushered in a new era in the treatment of low cardiac output states. Proper titration of MCS is essential for optimal therapeutic outcomes and relies on monitoring metrics of cardiac state. However, innovation in clinically determining these metrics has lagged compared to treatment options. Consequently, many rely on assumptions about the cardiovascular environment that are invalidated by the use of MCS, raising concerns about their reliability.
This work used thermodilution, the gold standard method for measuring a patient’s cardiac output, as well as a newly developed MCS-based method, to explore under what conditions traditional metrics are impacted by MCS. Data from porcine studies and clinical trials were used to examined how the validity of both measurement methods can be impacted by changes in a patient’s cardiac state as well as commonly used medical interventions like mechanical ventilation and pharmacologic treatment, with and without MCS present. Ultimately, we found that thermodilution remains valid under conditions where beat-to-beat variability in flow is low, a limitation not present in the new MCS-based method.
Translation of this work to the clinic will help better inform physicians on when thermodilution measurements should and should not be used to titrate MCS support due to possible unreliability. What’s more, understanding when and how traditional, “gold standard” metrics, such as thermodilution, fail is essential for validating newer, more reliable metrics like the MCS-based method. Both of these consequences will ultimately improving patient outcomes.
Thesis Supervisor:
Elazer R. Edelman, MD, PhD
Edward J. Poitras Professor of Health Sciences and Technology; Director, Institute for Medical Engineering and Science MIT
Thesis Committee Chair:
Joseph J. Frassica, MD, PhD
Professor of the Practice, Institute for Medical Engineering and Science, MIT
Thesis Readers:
Jerry Curran, PhD
Director, Academic Research at Abiomed
Steven P. Keller, MD, PhD
Assistant Professor of Medicine and Biomedical Engineering, Johns Hopkins Hospital
------------------------------------------------------------------------------------------------------
Zoom invitation –
Fiona K. Macleod is inviting you to a scheduled Zoom meeting.
Topic: Fiona Macleod Thesis Defense
Time: August 1, 2023, 02:00 PM Eastern Time (US and Canada)
Your participation is important to us: please notify hst [at] mit.edu (hst[at]mit[dot]edu), at least 3 business days in advance, if you require accommodations in order to access this event.
Join Zoom Meeting
https://mit.zoom.us/j/99591455033
Password: 055477
One tap mobile
+16465588656,,99591455033# US (New York)
+16699006833,,99591455033# US (San Jose)
Meeting ID: 995 9145 5033
US: +1 646 558 8656 or +1 669 900 6833
International Numbers: https://mit.zoom.us/u/a2Kw2daD2
Join by SIP
99591455033 [at] zoomcrc.com
Join by Skype for Business
https://mit.zoom.us/skype/99591455033